You are here

  • Home
  • Archive
  • Volume 10, Issue 12
  • Exploiting the immunogenic potential of standard of care radiation or cisplatin therapy in preclinical models of HPV-associated malignancies

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Exploiting the immunogenic potential of standard of care radiation or cisplatin therapy in preclinical models of HPV-associated malignancies

 

Online download statistics by month:

Online download statistics by month: December 2022 to January 2026

AbstractFullPdf
Dec 202230631685
Jan 202320420496
Feb 2023949847
Mar 2023838438
Apr 2023666733
May 2023525232
Jun 2023525329
Jul 2023626238
Aug 2023373919
Sep 2023323214
Oct 2023262625
Nov 2023393918
Dec 2023343428
Jan 2024575847
Feb 2024414122
Mar 2024515147
Apr 2024454545
May 2024505230
Jun 2024535529
Jul 2024596029
Aug 20245049112
Sep 2024373723
Oct 2024484935
Nov 2024515234
Dec 2024636433
Jan 2025323322
Feb 202513713721
Mar 2025424231
Apr 2025474733
May 2025202117
Jun 2025252520
Jul 2025220
Oct 2025550
Jan 2026001
Total200220311133